Latest report on Orphan Drugs Market of 67 pages now added by a leading business intelligence provider to MarketReportsOnline.com database.

Pune, India -- (SBWire) -- 06/28/2017 --An orphan disease refers to any rare disease which affects a smaller portion of population. Most of the rare diseases are genetic and therefore chronic. Presently, there are around 7000 rare diseases affecting approximately 5-6% of the global population. Half of the population of orphan disease patients is children as most of the genetic orphan diseases occur at birth or childhood.

Complete report available at http://www.marketreportsonline.com/605993.html.

Generally, orphan diseases are considered to be severe, progressive, degenerative, life-threatening or chronically debilitating diseases which can be caused genetically, infectiously or toxically. Despite knowing the causes of orphan diseases, most of these diseases are still non-curable or lack satisfactory treatments. Majority of the genetic orphan diseases are caused by defects in a single gene due to multiple mutations.

Orphan drug market is likely to witness a growth in future with the increasing development and approvals of ultra-rare drugs and rising developments in drugs for rare blood disease. The U.S. and Europe are the major contributors to the global orphan drugs market supported by increased numbers of orphan designations. Asia is likely to experience further growth with increasing drug approvals in Japan and improving healthcare facilities.

Purchase a copy of this "Orphan Drugs Market" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=605993.

The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure, improving economies and increasing prevalence of chronic diseases. Key trends of this market include progressing drug pipeline, rising treatment options in oncology and rising scope in gene therapy. However, there are some factors which can hinder growth of the market including high costs of drugs, increased competition from generic industry, insufficient disease information & research participants and deficiency of diagnostic systems and trained professionals.

The report "Orphan Drugs Market" provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S, Europe and Asia along with the global market. The report profiles key players of the market including Roche, Novartis, Bristol-Myers Squibb and Celgene.

Few Points from List of Tables & Charts:

List of Tables

Orphan Disease Prevalence in Different Nations
Orphan Drug Market Exclusivity
Orphan Drug Policies
Orphan Drugs Under Development (2016)

List of Charts

Types of Orphan Drugs
Orphan Drug Development
Global Orphan Drugs Market by Value (2012-2016)
Global Orphan Drugs Market Forecast by Value (2017-2021)
Global Orphan Drugs Market by Product (2016)
Global Orphan Drugs Share in Prescription Drugs Market (2012-2016)
Global Orphan Drugs Share Forecast in Prescription Drugs Market (2017-2021)
The U.S. Orphan Drugs Spending Forecast (2016-2021)
The U.S. Orphan Drug Volume (2012-2016)
The U.S. Orphan Drug Average & Median Cost per Patient (2012-2016)
The U.S. Orphan Drug Average & Median Cost per Patient Forecast (2017-2021)

Explore more related reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com